Paul Quinlan

Insider Reports History

Location
Newark, CA
Signature
/s/ Paul Quinlan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul Quinlan:

Company Role Class Num Shares Value Price $ Report Date Ownership
CymaBay Therapeutics, Inc. General Counsel Common Stock 0 $0 $2.94 22 Mar 2024 Direct
Oruka Therapeutics, Inc. General Counsel Employee Stock Option (right to buy) 162,500 22 Jan 2025 Direct
CymaBay Therapeutics, Inc. General Counsel Employee Stock Option (right to buy) 0 22 Mar 2024 Direct

Insider Reports Filed by Paul Quinlan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ORKA Oruka Therapeutics, Inc. 22 Jan 2025 1 $0 4 General Counsel 24 Jan 2025, 16:42
ORKA Oruka Therapeutics, Inc. 29 Aug 2024 0 $0 3 General Counsel and Secretary 06 Sep 2024, 17:03
/report/000095017024035453-quinlan-paul-t-2024-03-22 CymaBay Therapeutics, Inc. 22 Mar 2024 7 $0 4 General Counsel 22 Mar 2024, 16:59
/report/000106299324006510-quinlan-paul-t-2024-03-13 CymaBay Therapeutics, Inc. 13 Mar 2024 2 +$329,991 4 General Counsel 15 Mar 2024, 16:02
/report/000106299324001429-quinlan-paul-t-2024-01-24 CymaBay Therapeutics, Inc. 24 Jan 2024 2 $0 4 General Counsel 26 Jan 2024, 18:28
/report/000106299324000923-quinlan-paul-t-2024-01-16 CymaBay Therapeutics, Inc. 16 Jan 2024 3 -$103,198 4 General Counsel 16 Jan 2024, 19:07
/report/000106299323022636-quinlan-paul-t-2023-12-15 CymaBay Therapeutics, Inc. 15 Dec 2023 3 -$95,202 4 General Counsel 15 Dec 2023, 16:35
/report/000106299323021137-quinlan-paul-t-2023-11-15 CymaBay Therapeutics, Inc. 15 Nov 2023 3 -$72,189 4 General Counsel 17 Nov 2023, 17:57
/report/000106299323019547-quinlan-paul-t-2023-10-16 CymaBay Therapeutics, Inc. 16 Oct 2023 3 -$54,098 4 General Counsel 18 Oct 2023, 18:21
/report/000106299323018278-quinlan-paul-t-2023-09-15 CymaBay Therapeutics, Inc. 15 Sep 2023 7 -$738,321 4 General Counsel 19 Sep 2023, 18:23
/report/000106299323016606-quinlan-paul-t-2023-08-15 CymaBay Therapeutics, Inc. 15 Aug 2023 3 -$44,850 4 General Counsel 16 Aug 2023, 17:57
/report/000106299323014924-quinlan-paul-t-2023-07-14 CymaBay Therapeutics, Inc. 14 Jul 2023 3 -$44,350 4 General Counsel 14 Jul 2023, 18:52
/report/000106299323014259-quinlan-paul-t-2023-06-30 CymaBay Therapeutics, Inc. 30 Jun 2023 3 -$35,550 4 General Counsel 30 Jun 2023, 16:51
/report/000106299323011430-quinlan-paul-t-2023-05-15 CymaBay Therapeutics, Inc. 15 May 2023 3 -$37,131 4 General Counsel 17 May 2023, 19:11
/report/000106299323001488-quinlan-paul-t-2023-01-25 CymaBay Therapeutics, Inc. 25 Jan 2023 1 $0 4 General Counsel 27 Jan 2023, 15:23
/report/000106299322001705-quinlan-paul-t-2022-01-25 CymaBay Therapeutics, Inc. 25 Jan 2022 1 $0 4 General Counsel 27 Jan 2022, 15:59